Caroline Naylor
Family · Raynham, MANPI 1922619170
Payments from drug & device makers
Across 88 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$586
- Teva Pharmaceuticals USA, Inc.$306
- GSK$225
- Regeneron Healthcare Solutions, Inc.$106
- Pfizer$73
- Aimmune Therapeutics, Inc.$47
- plus $282 from 12 others
What the payments were for
- Food & beverage$1,626100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $586 |
| Teva Pharmaceuticals USA, Inc. | 22 | $306 |
| GSK | 13 | $225 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Pfizer | 3 | $73 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Sanofi | 2 | $46 |
| Kaleo, Inc. | 2 | $45 |
| Verona Pharma, Inc. | 1 | $24 |
| Covis Pharma GmbH | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Grifols USA, LLC | 1 | $16 |
| CSL Behring | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Optinose US, Inc. | 1 | $14 |
How this compares
$1,626 in reported general payments places this provider in the 85th percentile of 2,320 family providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 27 | $329 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $326 |
| Atorvastatin Calcium | 20 | $273 |
| Doxycycline Monohydrate | 24 | $195 |
| Prednisone | 20 | $183 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $162 |
| Levothyroxine Sodium | 11 | $160 |
| Triamcinolone Acetonide | 15 | $156 |
| Sertraline Hcl | 11 | $108 |
| Amlodipine Besylate | 23 | $104 |
| Losartan Potassium | 11 | $103 |
| Metformin Hcl | 17 | $67 |
| Tramadol Hcl | 11 | $45 |
| Hydrochlorothiazide | 16 | $44 |
| Lisinopril | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other family in Raynham
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.